Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II study of decitabine as MDS treatment enrolling patients

March 28, 2001

Glivec granted priority review status in U.S.

March 28, 2001

FDA denies approval of BMS's UFT capsules + leucovorin tablets

March 28, 2001

SOD mimetic M-40403 may allow high-dose IL-2 immunotherapy in advanced cancers

March 27, 2001

Preclinical data presented for TLK-199 at AACR meeting

March 27, 2001

SafeScience's anticancer drug GBC-590 shows activity in phase II trial

March 27, 2001

AVI BioPharma's antisense agent slows tumor growth in mice

March 26, 2001

MGI Pharma commences new phase II trial of irofulven for treatment of ovarian cancer

March 26, 2001

Lynx Therapeutics and UroGene collaborate to identify anticancer genes

March 26, 2001

Hungarian scientists claim new series of heterocyclic angiogenesis inhibitors

March 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...